37 
“ (h) except as provided in section 1816 (/) , to utilize, with their 
■consent, the services, personnel, and facilities of other Federal 
agencies and of state and private agencies and instrumentalities 
with or without reimbursement therefor; 
“(5) except as provided in section 1816(f) , to enter into and 
'perform such contracts, leases, cooperative agreements, or other 
transactions as may be necessary or appropriate in the conduct 
of the work of the Commission and on such terms as the Commis- 
sion may deem appropriate, with any agency or instrumentality 
of the United States, or with any state, territory or possession, or 
■any political subdivision thereof , or with any public or private 
person, firm, association, corporation , independent testing labora- 
tory . or institution ; 
“(<?) to monitor compliance by the owners or operators of a 
licensed facility and persons authorized by a license to engage in 
recombinant DNA activities in connection with a licensed facility 
with the requirements of this title ; and 
“(7) to undertake such other activities as are incidental to en- 
forcement of the provisions of this title. 
u (b) The Commission shall encourage through contracts, the de- 
velopment of effective epidemiological methods and safety monitoring 
technologies to identify and follow the production and dissemination 
of recombinant DNA and the biological or chemical products thereof. 
u (c) The Commission shall encourage on a continuing basis studies 
designed to assess the risks to human health and the environment 
which may be presented by recombinant DNA activities. The Com- 
mission shall insure that the findings of such studies shall be main- 
tained and readily accessible to all interested persons. 
'‘'‘GENERAL REQUIREMENTS 
u Sec. 1803. (a) Effective two hundred and sixty-five days after the 
date of the enactment of this title, no person may engage in recorri- 
binant DNA activities in the States or in any area sub feet to the 
jurisdiction of the United, States unless such activities are conducted 
in a facility which is licensed under this part authorizing such activi- 
ties to be conducted in such facility. 
li (b)(1) A license to authorize recombinant DNA activities to be 
conducted in a f acility shall be issued only upon an application made 
by persons who own or operate a facility in such form and manner 
as may be prescribed by the Commission. An application for such a 
license shall include — 
“(J.) the names of persons who own or operate the facility 
to be licensed and the location of such facility ; 
“ (B ) the names, addresses and qualifications of persons to be 
authorized by the license to engage in recombinant DNA activities 
in connection with such facility ; 
“ (C) a description of the proposed recombinant DNA projects 
to be conducted in such facility; 
“ (D) a description of such facility and materials to be used 
in connection with recombinant DNA activities at such facility y 
“ (E) certification to the Commission that such facility and such 
activities will meet all applicable requirements prescribed by reg- 
[ 777 ] 
